ClinConnect ClinConnect Logo
Search / Trial NCT06671184

Nomogram for Predicting Difficult Transoral and Submental Thyroidectomy

Launched by SHANGHAI 6TH PEOPLE'S HOSPITAL · Nov 1, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Differentiated Thyroid Cancer Transoral And Submental Thyroidectomy Surgical Difficulty

ClinConnect Summary

This clinical trial is studying a new way to predict how difficult it might be to perform a specific type of thyroid surgery called transoral and submental thyroidectomy (TOaST) in patients with differentiated thyroid cancer. The researchers want to identify certain factors before surgery that could indicate whether the procedure will be easy or challenging. By doing this, they hope to create a tool that can help doctors better prepare for the surgery and meet patients' cosmetic expectations.

To participate in this trial, patients must have a diagnosis of differentiated thyroid cancer with tumors that are no larger than 4 cm and no signs of cancer spread to the lymph nodes or other parts of the body. Additionally, the trial is looking for patients who have had certain previous surgeries on their thyroid and lymph nodes. Participants can expect to be part of a study that aims to improve surgical outcomes and patient satisfaction. If you're considering this option, it's important to know that there are specific criteria that must be met to join, which helps ensure safety and effectiveness in the research.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Clinical diagnosis of differentiated thyroid cancer with a maximum diameter not exceeding 4 cm
  • Absence of suspicious lateral lymph nodes or distant metastases
  • Participants with high cosmetic expectations
  • Participants who underwent total thyroidectomy and central lymph node dissection.
  • Exclusion Criteria:
  • Participants with fusion or fixation of lymph nodes in the neck
  • Participants with history of neck surgery or radiation
  • Participants with vocal fold fixation by preoperative fibrolaryngoscope
  • Participants with preoperative examination suggestive of extrathyroidal invasion
  • Participants with a significantly restricted neck

About Shanghai 6th People's Hospital

Shanghai 6th People's Hospital is a leading medical institution in China, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital focuses on a wide range of therapeutic areas, striving to enhance patient outcomes and contribute to medical knowledge. With a dedicated team of experienced researchers and clinicians, Shanghai 6th People's Hospital emphasizes rigorous scientific methodology and ethical standards, ensuring that all trials are conducted with the utmost integrity and patient safety in mind. Through collaboration with various stakeholders, the hospital aims to bridge the gap between clinical research and real-world application, ultimately improving healthcare delivery both locally and globally.

Locations

Shanghai, Shanghai, China

Patients applied

0 patients applied

Trial Officials

Ling Zhan, Doctor

Principal Investigator

Shanghai 6th People's Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported